Akebia Therapeutics reports strong Q2 2025 earnings, driven by Vafseo’s 55% sales growth. Explore plans for expanded patient access & trial updates.

Truist analyst David MacDonald lowered the firm’s price target on DaVita (DVA) to $148 from $164 and keeps a Hold rating on the shares. The firm is adjusting its estimates to reflect the company’s Q2 ...

Detailed price information for Davita Healthcare Partners Inc (DVA-N) from The Globe and Mail including charting and trades.

Detailed price information for Davita Healthcare Partners Inc (DVA-N) from The Globe and Mail including charting and trades.

Sower Investment Partners has purchased Rochester’s Broadway Commons for $19.75M. The site includes Total Wine, Petco, ...

Columbia University has been targeted in a cyberattack where hackers stole the personal information of students, applicants, ...

A Google Salesforce instance may have been targeted as part of a ShinyHunters campaign that hit several major companies.